Open MSAC consultations

6 results

  • MSAC Consultation Survey - Application 1790

    MSAC application 1790 POLE genotyping for the molecular classification of endometrial cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Closes 13 February 2026

  • MSAC Consultation Survey - Application 1796

    MSAC application 1796 ADAMTS13 testing for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 13 February 2026

  • MSAC Consultation Survey - Application 1804

    MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Closes 13 February 2026

  • MSAC Consultation Survey - Application 1805

    MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 13 February 2026

  • MSAC Consultation Survey - Application 1806

    MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 13 February 2026

  • MSAC Consultation Survey - Application 1657.1

    MSAC application 1657.1 Rhenium-188 brachytherapy for non-melanoma skin cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Closes 13 February 2026
6 results. Page 1 of 1